BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang A J, Zhang J, Xiao M, Wang S, Wang B J, Guo Y, Tang Y, Gu J. Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways. Cell Mol Life Sci 2021;78:3105-25. [PMID: 33438055 DOI: 10.1007/s00018-020-03729-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lu G, Liu Q, Gao T, Li J, Zhang J, Chen O, Cao C, Mao M, Xiao M, Zhang X, Wang J, Guo Y, Tang Y, Gu J. Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway. Nutrients 2022;14:4017. [DOI: 10.3390/nu14194017] [Reference Citation Analysis]
2 Qian J, Wan W, Fan M. HMOX1 silencing prevents doxorubicin-induced cardiomyocyte injury, mitochondrial dysfunction, and ferroptosis by downregulating CTGF. Gen Thorac Cardiovasc Surg 2022. [PMID: 36008747 DOI: 10.1007/s11748-022-01867-7] [Reference Citation Analysis]
3 Zhang J, Xie B, Tang Y, Zhou B, Wang Q, Ge Q, Zhou Y, Gu T. Downregulation of miR-34c-5p alleviates chronic intermittent hypoxia-induced myocardial damage by targeting sirtuin 1. J Biochem Mol Toxicol 2022;:e23164. [PMID: 35848756 DOI: 10.1002/jbt.23164] [Reference Citation Analysis]
4 Ahmad N, Ullah A, Chu P, Tian W, Tang Z, Sun Z. Doxorubicin induced cardio toxicity through sirtuins mediated mitochondrial disruption. Chemico-Biological Interactions 2022. [DOI: 10.1016/j.cbi.2022.110028] [Reference Citation Analysis]
5 Tang X, Wang Z, Hu S, Zhou B. Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation. Pharmaceutics 2022;14:1313. [DOI: 10.3390/pharmaceutics14071313] [Reference Citation Analysis]
6 Wang A J, Tang Y, Zhang J, Wang B J, Xiao M, Lu G, Li J, Liu Q, Guo Y, Gu J. Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2. Redox Biol 2022;52:102310. [PMID: 35452917 DOI: 10.1016/j.redox.2022.102310] [Reference Citation Analysis]
7 Wu BB, Leung KT, Poon EN. Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity. Int J Mol Sci 2022;23:1912. [PMID: 35163838 DOI: 10.3390/ijms23031912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 He L, Wang J, Yang Y, Zou P, Xia Z, Li J. SIRT4 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the AKT/mTOR/Autophagy Pathway. Toxicology 2022. [DOI: 10.1016/j.tox.2022.153119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Xiao M, Tang Y, Wang J (a), Lu G, Niu J, Wang J (b), Li J, Liu Q, Wang Z, Huang Z, Guo Y, Gao T, Zhang X, Yue S, Gu J. A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity. Redox Biol 2022;49:102219. [PMID: 34990928 DOI: 10.1016/j.redox.2021.102219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Avagimyan A, Gvianishvili T, Gogiashvili L, Kakturskiy L, Sarrafzadegan N, Aznauryan A. Chemotherapy, hypothyroidism and oral dysbiosis as a novel risk factor of cardiovascular pathology development. Curr Probl Cardiol 2021;:101051. [PMID: 34800544 DOI: 10.1016/j.cpcardiol.2021.101051] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Xu L, Wang C, Zou Z, Wu Z. Ozone Attenuated H9c2 Cell Injury Induced by Doxorubicin. J Cardiovasc Pharmacol 2021;78:e86-93. [PMID: 33929391 DOI: 10.1097/FJC.0000000000001043] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Avagimyan A, Kakturskiy L, Heshmat-Ghahdarijani K, Pogosova N, Sarrafzadegan N. Anthracycline Associated Disturbances of Cardiovascular Homeostasis. Curr Probl Cardiol 2021;:100909. [PMID: 34167841 DOI: 10.1016/j.cpcardiol.2021.100909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
13 Zhao G, Aghakeshmiri S, Chen YT, Zhang HM, Yip F, Yang D. NFAT5-Mediated Signalling Pathways in Viral Infection and Cardiovascular Dysfunction. Int J Mol Sci 2021;22:4872. [PMID: 34064510 DOI: 10.3390/ijms22094872] [Reference Citation Analysis]
14 Zhang L, Feng M, Wang X, Zhang H, Ding J, Cheng Z, Qian L. Peptide Szeto‑Schiller 31 ameliorates doxorubicin‑induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway. Int J Mol Med 2021;47:63. [PMID: 33649779 DOI: 10.3892/ijmm.2021.4896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]